Control of Head Lice Infestations in Children and Adults
NCT00731718 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 543
Last updated 2008-08-11
Summary
The goal of this study is to see if heated air will kill head lice and their eggs. The treatment visit is approximately 1 hour long with a follow up phone call.
Conditions
- Pediculosis
Interventions
- DEVICE
-
lousebuster
Subject serves as own control the length of treatment is approximately 30 minutes for full head treatment
Sponsors & Collaborators
-
Larada Sciences, Inc.
lead INDUSTRY
Principal Investigators
-
Dale Clayton, PhD/Biology · Larada Sciences Inc., University of Utah
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-06-30
- Primary Completion
- 2008-06-30
- Completion
- 2008-07-31
Countries
- United States
Study Locations
More Related Trials
-
Determining the Complete Protection Time of an Insect Repellent With 30% Citriodiol® Against Three Species of Ticks.
NCT03708120 ·Status: COMPLETED ·Phase: NA
-
Reducing Delay in Vaccination of Children: Logistic Barriers
NCT03516682 ·Status: COMPLETED ·Phase: NA
-
Development and Testing of ADEPT: A Parent Decision Support for Childhood Vaccinations
NCT04496453 ·Status: COMPLETED ·Phase: NA
-
A School Health Center Intervention to Increase Adolescent Vaccination
NCT01595542 ·Status: COMPLETED ·Phase: NA
-
COVID-19 Booster Dose Reminder/Recall for Adolescents
NCT05571657 ·Status: UNKNOWN ·Phase: NA
-
The Efficacy of Reminders to Complete HPV Series
NCT01731496 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate Long-term Safety of Ecopipam Tablets in Children, Adolescents and Adults With Tourette's Disorder
NCT06021522 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluation of Vaccination Reminder/Recall Systems for Adolescent Patients
NCT00715234 ·Status: COMPLETED ·Phase: NA
-
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
NCT03000998 ·Status: COMPLETED ·Phase: NA
-
Tdap Vaccination for Infant Caregivers
NCT01233401 ·Status: COMPLETED
-
School Located Adolescent Vaccination Study
NCT01719679 ·Status: COMPLETED ·Phase: NA
-
Parental Views Related to Colorado State Legislation About Vaccinations, Schools, and Child Care Centers
NCT02957344 ·Status: COMPLETED
-
Immunogenicity and Safety of BoostrixTM Using a New Syringe in 10 to 15-year Old Adolescents
NCT01362322 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding Typhoid Disease After Vaccination
NCT01405521 ·Status: COMPLETED ·Phase: PHASE2
-
MAPS & ITEC Cohorts: 6-8 Years Follow-up
NCT03763630 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Tdap Vaccine Compared to DTaP Vaccine in Children 4 to 6 Years of Age
NCT00467519 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age
NCT00524732 ·Status: COMPLETED
-
Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9
NCT00489970 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Trial of EPI-743 for Adults With Tourette Syndrome
NCT01719523 ·Status: COMPLETED ·Phase: PHASE1
-
Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
NCT01738477 ·Status: COMPLETED ·Phase: PHASE3
-
Ecopipam Tablets to Study Tourette's Syndrome in Children and Adolescents
NCT04007991 ·Status: COMPLETED ·Phase: PHASE2
-
Adolescent Vaccination Kiosk Project
NCT01622608 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity of Adacel® and BOOSTRIX® Vaccines in Adolescents
NCT01629589 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of Boostrix™10 Years After Previous Booster Vaccination
NCT01147900 ·Status: COMPLETED ·Phase: PHASE4